TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) — PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV: PSYB) (the “ Company”) is pleased to announce that at the opening of the market today, the Company’s subordinate voting shares will commence trading on the TSX Venture Exchange (the “TSXV”) under the ticker symbol “PSYB”. On February 19, 2021, the Company announced the closing of its…


Previous article‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU
Next articlePure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Inks First CBD Oil Commercial Sale; Looks to Grow in Key Spaces